SCHEMBL7533064

SCHEMBL7533064

COc1ccc(Oc2ccc(S(=O)(=O)N3CCCCC3C(=O)NO)cc2)cc1

nearest known ligand 0.91

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 19/20 0.91
MMP3 P08254 15/20 0.91
MMP13 P45452 14/20 0.91
MMP7 P09237 13/20 0.91
MMP9 P14780 12/20 0.72
MMP2 P08253 3/20 0.72
MMP8 P22894 2/20 0.72
ADAM17 P78536 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533059 1.00 MMP1 (0.91) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7923785 0.99 MMP1 (0.93) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7923788 0.99 MMP1 (0.93) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7763139 0.96 MMP1 (0.98) MMP1MMP3MMP13MMP7MMP9
SCHEMBL6981692 0.95 MMP1 (1.00) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7393667 0.95 MMP1 (1.00) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7349862 0.93 MMP1 (0.91) MMP1MMP3MMP13MMP7MMP9
SCHEMBL6272327 0.91 MMP1 (0.87) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7535528 0.91 MMP1 (0.75) MMP1MMP3MMP13MMP7MMP9
SCHEMBL7535524 0.91 MMP1 (0.75) MMP1MMP3MMP13MMP7MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US claimed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO claimed
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US disclosed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO disclosed